Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer.

Saved in:
Bibliographic Details
Title: Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer.
Authors: Schram, A. M.1 schrama@mskcc.org, Goto, K.2, Kim, D.-W.3, Macarulla, T.4, Hollebecque, A.5, O'Reilly, E. M.1, Ou, S.-H. I.6, Rodon, J.7, Rha, S. Y.8, Nishino, K.9, Duruisseaux, M.10,11,12, Park, J. O.13, Neuzillet, C.14, Liu, S. V.15, Weinberg, B. A.15, Cleary, J. M.16,17, Calvo, E.18, Umemoto, K.19, Nagasaka, M.19,20, Springfeld, C.21
Source: New England Journal of Medicine. 2/6/2025, Vol. 392 Issue 6, p566-576. 11p.
Database: Academic Search Ultimate
Description
ISSN:00284793
DOI:10.1056/NEJM022405008